{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:34:07Z","timestamp":1778038447668,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874288"],"award-info":[{"award-number":["81874288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003590"],"award-info":[{"award-number":["82003590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92053105"],"award-info":[{"award-number":["92053105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019LZL004"],"award-info":[{"award-number":["ZR2019LZL004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020QH342"],"award-info":[{"award-number":["ZR2020QH342"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.bioorg.2022.105643","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T12:00:47Z","timestamp":1643112047000},"page":"105643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors"],"prefix":"10.1016","volume":"121","author":[{"given":"Xiao","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zefu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wandi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuben","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.105643_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113038","article-title":"Development of Mcl-1 inhibitors for cancer therapy","volume":"210","author":"Negi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semcdb.2017.04.001","article-title":"The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation","volume":"72","author":"Birkinshaw","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2022.105643_b0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/leu.2013.216","article-title":"The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma","volume":"28","author":"Touzeau","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2022.105643_b0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2022.105643_b0025","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2022.105643_b0030","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/onc.2010.559","article-title":"Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2022.105643_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2022.105643_b0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1873-3468.12497","article-title":"Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors","volume":"591","author":"Lee","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2022.105643_b0045","first-page":"1566","article-title":"A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia, Cancer","volume":"8","author":"Ramsey","year":"2018","journal-title":"Discovery"},{"key":"10.1016\/j.bioorg.2022.105643_b0050","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/acs.jmedchem.8b01991","article-title":"Discovery of Potent Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer","volume":"62","author":"Lee","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2022.105643_b0060","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/2159-8290.CD-18-0387","article-title":"AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies","volume":"8","author":"Caenepeel","year":"2018","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.bioorg.2022.105643_b0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsmedchemlett.6b00464","article-title":"Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors","volume":"8","author":"Johannes","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105643_b0070","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-018-07551-w","article-title":"Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia","volume":"9","author":"Tron","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2022.105643_b0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/1535-7163.MCT-12-0767","article-title":"A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo","volume":"13","author":"Abulwerdi","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2022.105643_b0080","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/acs.jmedchem.9b02047","article-title":"Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent","volume":"63","author":"Lu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115851","article-title":"Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment","volume":"29","author":"Xia","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0090","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1016\/j.bmc.2015.10.023","article-title":"Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors","volume":"23","author":"Wang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0095","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.bmc.2019.05.003","article-title":"Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2\/Mcl-1 dual inhibitors","volume":"27","author":"Chen","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112142","article-title":"Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors","volume":"191","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105643_b0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tcb.2019.03.004","article-title":"Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy","volume":"29","author":"Senichkin","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioorg.2022.105643_b0110","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/cmdc.201000484","article-title":"Discovery and Development of Thiazolo 3,2-a pyrimidinone Derivatives as General Inhibitors of Bcl-2 Family Proteins","volume":"6","author":"Zhou","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2022.105643_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ab.2004.05.055","article-title":"Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization","volume":"332","author":"Nikolovska-Coleska","year":"2004","journal-title":"Anal. Biochem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:22:39Z","timestamp":1758615759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":23,"alternative-id":["S0045206822000487"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105643","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105643"}}